LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872104. A total of 119 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $851,000 | – | 900,900 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 30,248,505 | $28,434,000 | 99.96% |
| Artal Group S.A. | 402,625,866 | $378,492,000 | 17.50% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 2,586,881 | $2,432,000 | 1.51% |
| NEA Management Company, LLC | 16,676,000 | $15,675,000 | 0.71% |
| Alden Global Capital LLC | 900,900 | $851,000 | 0.60% |
| Rhenman & Partners Asset Management AB | 1,594,805 | $1,506,000 | 0.25% |
| MASTERS CAPITAL MANAGEMENT LLC | 7,964,370 | $7,521,000 | 0.22% |
| SABBY MANAGEMENT, LLC | 5,371,800 | $5,073,000 | 0.21% |
| Round Table Services, LLC | 151,280 | $143,000 | 0.11% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 250,000 | $236,000 | 0.09% |